{
    "address1": "Paasheuvelweg 25",
    "city": "Amsterdam",
    "zip": "1105 BP",
    "country": "Netherlands",
    "phone": "31 20 240 6000",
    "website": "https://www.uniqure.com",
    "industry": "Biotechnology",
    "industryDisp": "Biotechnology",
    "sector": "Healthcare",
    "sectorDisp": "Healthcare",
    "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.",
    "fullTimeEmployees": 501,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Mr. Matthew Craig Kapusta",
            "age": 50,
            "title": "CEO & Exec. Director",
            "yearBorn": 1972,
            "fiscalYear": 2022,
            "totalPay": 1157887,
            "exercisedValue": 0,
            "unexercisedValue": 4726089
        },
        {
            "maxAge": 1,
            "name": "Dr. Ricardo  Dolmetsch Ph.D.",
            "age": 53,
            "title": "Pres & Chief Scientific Officer",
            "yearBorn": 1969,
            "fiscalYear": 2022,
            "totalPay": 911070,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Christian  Klemt",
            "age": 49,
            "title": "CFO, Principal Financial Officer & GM of Amsterdam Site",
            "yearBorn": 1973,
            "fiscalYear": 2022,
            "totalPay": 566360,
            "exercisedValue": 0,
            "unexercisedValue": 362614
        },
        {
            "maxAge": 1,
            "name": "Mr. Pierre  Caloz",
            "age": 50,
            "title": "Chief Operating Officer",
            "yearBorn": 1972,
            "fiscalYear": 2022,
            "totalPay": 951104,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Prof. Hugo  Katus",
            "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Jeannette  Potts J.D., Ph.D.",
            "age": 60,
            "title": "Chief Legal & Compliance Officer",
            "yearBorn": 1962,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Tamara  Tugal Ph.D., MBA",
            "title": "Bus. Devel. Director",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Erin  Boyer",
            "title": "Chief People & Culture Office",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Maria E. Cantor",
            "age": 54,
            "title": "Chief Corp. Affairs Officer",
            "yearBorn": 1968,
            "fiscalYear": 2018,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Richard  Porter Ph.D.",
            "title": "Chief Bus. Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 4,
    "boardRisk": 3,
    "compensationRisk": 5,
    "shareHolderRightsRisk": 1,
    "overallRisk": 2,
    "governanceEpochDate": 1690848000,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 8.57,
    "open": 8.59,
    "dayLow": 8.36,
    "dayHigh": 8.73,
    "regularMarketPreviousClose": 8.57,
    "regularMarketOpen": 8.59,
    "regularMarketDayLow": 8.36,
    "regularMarketDayHigh": 8.73,
    "payoutRatio": 0.0,
    "beta": 1.023207,
    "forwardPE": -1.8311965,
    "volume": 349600,
    "regularMarketVolume": 349600,
    "averageVolume": 939172,
    "averageVolume10days": 541120,
    "averageDailyVolume10Day": 541120,
    "bid": 8.57,
    "ask": 8.57,
    "bidSize": 800,
    "askSize": 800,
    "marketCap": 413474208,
    "fiftyTwoWeekLow": 8.2,
    "fiftyTwoWeekHigh": 28.255,
    "priceToSalesTrailing12Months": 3.6936798,
    "fiftyDayAverage": 10.6178,
    "twoHundredDayAverage": 18.59115,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": -70184000,
    "profitMargins": -1.6683,
    "floatShares": 41869785,
    "sharesOutstanding": 47584000,
    "sharesShort": 2175829,
    "sharesShortPriorMonth": 2410560,
    "sharesShortPreviousMonthDate": 1688083200,
    "dateShortInterest": 1690761600,
    "sharesPercentSharesOut": 0.0456,
    "heldPercentInsiders": 0.07298,
    "heldPercentInstitutions": 0.90760005,
    "shortRatio": 2.66,
    "shortPercentOfFloat": 0.051599998,
    "impliedSharesOutstanding": 48246700,
    "bookValue": 7.407,
    "priceToBook": 1.1570135,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "netIncomeToCommon": -186751008,
    "trailingEps": -3.87,
    "forwardEps": -4.68,
    "enterpriseToRevenue": -0.627,
    "enterpriseToEbitda": 0.448,
    "52WeekChange": -0.5623085,
    "SandP52WeekChange": 0.09306288,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "QURE",
    "underlyingSymbol": "QURE",
    "shortName": "uniQure N.V.",
    "longName": "uniQure N.V.",
    "firstTradeDateEpochUtc": 1391610600,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "uuid": "e051aa7b-edc2-3bc7-a8c8-c2e424dc5a80",
    "messageBoardId": "finmb_171029664",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 8.57,
    "targetHighPrice": 56.0,
    "targetLowPrice": 14.0,
    "targetMeanPrice": 36.71,
    "targetMedianPrice": 36.5,
    "recommendationMean": 1.7,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 14,
    "totalCash": 628587008,
    "totalCashPerShare": 13.177,
    "ebitda": -156528000,
    "totalDebt": 139084992,
    "quickRatio": 10.696,
    "currentRatio": 11.074,
    "totalRevenue": 111941000,
    "debtToEquity": 39.365,
    "revenuePerShare": 2.372,
    "returnOnAssets": -0.12628001,
    "returnOnEquity": -0.44474998,
    "grossProfits": -87370000,
    "freeCashflow": -167576128,
    "operatingCashflow": -238970000,
    "revenueGrowth": 3.873,
    "grossMargins": -0.90505,
    "ebitdaMargins": -1.39831,
    "operatingMargins": -1.4836099,
    "financialCurrency": "USD",
    "trailingPegRatio": null,
    "parent_etfs": [
        "GNOM"
    ]
}